This article is- freely available
- re-usable
Article
New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses
Stefano Rusconi 1,*

,
Mirko Lo Cicero 1 ,
Ottavia Viganò 1 ,
Francesca Sirianni 1 ,
Elisabetta Bulgheroni 1 ,
Stefania Ferramosca 1 ,
Andrea Bencini 2 ,
Antonio Bianchi 2 ,
Lidia Ruiz 3 ,
Cecilia Cabrera 3 ,
Javier Martinez-Picado 3 
,
Claudiu T. Supuran 2 
and
Massimo Galli 1
1
Dipartimento di Scienze Cliniche “Luigi Sacco”, Sezione di Malattie Infettive e Immunopatologia, Università degli Studi, Ospedale Luigi Sacco, via G.B. Grassi 74, 20157 Milano, Italy
2
Università degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino (Firenze), Italy
3
IrsiCaixa Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain
* Author to whom correspondence should be addressed.
Received: 2 April 2009; in revised form: 20 May 2009 / Accepted: 21 May 2009 / Published: 22 May 2009
Abstract: Considering as a lead molecule the chemokine CXCR4 receptor antagonist AMD-3100, which shows significant anti-HIV activity in vitro and in vivo, we investigated a series of structurally related macrocyclic polyamines incorporating o,o’-phenanthroline or 2,2’-bipyridyl scaffolds as potential antiviral agents with lower toxicity and increased activity against both wild type X4-tropic and dual tropic HIV strains. The antiviral activity of these compounds was evaluated by susceptibility assays in PBMC (Peripheral Blood Mononuclear Cells) and compared to that of AMD-3100. The newly investigated compounds showed IC50s values in the low micromolar range and significantly inhibited the viral replication of wild type X4-tropic isolate and dual tropic strains. These macrocyclic polyamines constitute a promising class of HIV entry inhibitors.
Keywords: HIV-1; co-receptors; CXCR4; macrocyclic polyamines
Article Statistics
Click here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Rusconi, S.; Cicero, M.L.; Viganò, O.; Sirianni, F.; Bulgheroni, E.; Ferramosca, S.; Bencini, A.; Bianchi, A.; Ruiz, L.; Cabrera, C.; Martinez-Picado, J.; Supuran, C.T.; Galli, M. New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses. Molecules 2009, 14, 1927-1937.
AMA Style
Rusconi S, Cicero ML, Viganò O, Sirianni F, Bulgheroni E, Ferramosca S, Bencini A, Bianchi A, Ruiz L, Cabrera C, Martinez-Picado J, Supuran CT, Galli M. New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses. Molecules. 2009; 14(5):1927-1937.
Chicago/Turabian Style
Rusconi, Stefano; Cicero, Mirko Lo; Viganò, Ottavia; Sirianni, Francesca; Bulgheroni, Elisabetta; Ferramosca, Stefania; Bencini, Andrea; Bianchi, Antonio; Ruiz, Lidia; Cabrera, Cecilia; Martinez-Picado, Javier; Supuran, Claudiu T.; Galli, Massimo. 2009. "New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses." Molecules 14, no. 5: 1927-1937.